What Is Vasotocin? Definition and What Research Reports

Definition

Vasotocin — most often written in full as arginine vasotocin and abbreviated AVT — is a small peptide hormone and neuropeptide composed of nine amino acids (a nonapeptide) with an internal disulfide bridge, produced mainly by neurons in the hypothalamus and released into circulation from the posterior pituitary (neurohypophysis), as well as acting locally within the brain. It is the principal neurohypophysial peptide of non-mammalian vertebrates — bony fish, amphibians, reptiles and birds — and is structurally and functionally the counterpart of arginine vasopressin (AVP) in mammals, differing from it by a single amino acid residue. In the peptide literature the term appears both as the name of the molecule itself and as a label for the wider oxytocin–vasotocin family, a set of related ligands and receptors that a 2021 nomenclature paper described as spanning vertebrate and invertebrate lineages and proposed to unify under a single naming system (PMID 33911268).

This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about health, medication or a specific compound. Nothing here describes a protocol, and no dosing information is provided.

What class of molecule it is and where it comes from

Vasotocin sits in the same structural class as oxytocin, vasopressin, isotocin and mesotocin: short cyclic nonapeptides built around a six-residue ring closed by a disulfide bond, with a three-residue tail. These peptides are synthesised as larger precursor proteins in magnocellular and parvocellular hypothalamic neurons, cleaved during axonal transport, and stored for release. Because the family members differ by only one or two residues, they show substantial cross-reactivity at each other's receptors — a point the guppy study made directly when researchers reported that arginine vasotocin activated isotocin receptors and induced COX2 expression in that species (PMID 33967951).

Evolutionarily, vasotocin is generally treated as the ancestral vertebrate form from which vasopressin arose in mammals. The 2021 Nature analysis of the oxytocin–vasotocin ligand and receptor families argued that the historical species-by-species naming of these peptides and their receptors had become confusing enough to warrant a universal nomenclature (PMID 33911268). That is why some recent human papers use "vasotocin receptor" terminology for genes older literature called vasopressin receptors — for example, a 2023 imaging-genetics study that used vasotocin receptor gene genotypes as the variable of interest (PMID 37990008).

Related terms at a glance

How the term is used in peptide research

Vasotocin appears in the research literature in three broad ways. First, as an endogenous signalling molecule measured in brain tissue or plasma — for example, work in the round goby in which researchers reported that social context affected aggression alongside brain vasotocin and isotocin levels (PMID 31834553). Second, as a neuroanatomical marker: studies map vasotocin-expressing cell groups and count their activation under different behavioural conditions, as in an experiment that documented differential activation of vasotocin neurons in contexts that elicited aggression versus courtship (PMID 27609648). Third, as an experimental probe in animal models, where the peptide is administered or its gene deleted to observe what changes — a design used in zebrafish, where the study found that knock-out of vasotocin reduced reproductive success in females (PMID 37670879/).

The term is almost entirely a research and comparative-endocrinology label. It is not the name of an approved human medicine, and the literature summarised here is dominated by fish, amphibian, reptile and bird models plus human genotype association work.

What the Published Literature Reports

Social behaviour, aggression and courtship

A 2017 review characterised arginine vasotocin as the social neuropeptide of amphibians and reptiles, describing its involvement across courtship, aggression and other social displays in those groups (PMID 28824546). Consistent with that framing, researchers reported that vasotocin neurons were differentially activated in contexts eliciting aggression compared with contexts eliciting courtship (PMID 27609648), and that in the round goby social context affected both aggression and brain vasotocin and isotocin levels (PMID 31834553). In medaka, a 2024 study described male-specific vasotocin expression in the tuberal hypothalamus that was androgen dependent and, the authors proposed, probably related to aggression (PMID 37923055).

Findings in birds and frogs have been more nuanced. In the common waxbill, a 2024 report described arginine vasotocin as modulating both social and non-social behaviour rather than acting on a single social axis (PMID 39299181). In Cope's gray treefrog, researchers reported that arginine vasotocin affected motivation to call but did not alter calling plasticity (PMID 34401940) — an example of the peptide influencing one behavioural component while leaving another unchanged.

Reproduction and peripheral actions

Beyond behaviour, vasotocin has been studied as a direct regulator of reproductive tissue. A 2024 study in adult zebrafish reported that arginine vasotocin directly regulated spermatogenesis in the testes (PMID 38928267), and a zebrafish knock-out study reported reduced reproductive success in females lacking vasotocin (PMID 37670879/). In ovoviviparous guppies, the study found that arginine vasotocin activated isotocin receptors directly and induced COX2 expression (PMID 33967951), illustrating receptor cross-talk within the family.

Human-relevant work: receptor genetics

Human studies in this verified set concern receptor gene variation rather than administration of the peptide. A 2022 paper examined oxytocin and vasotocin receptor variation in the context of the evolution of human prosociality (PMID 35757177), and a 2023 Translational Psychiatry study reported that vasotocin receptor gene genotypes moderated the relationship between cortical thickness and sensory processing (PMID 37990008). Both are association and moderation analyses; neither describes giving vasotocin to people.

Adverse Events and Safety: What Studies Report

The verified literature summarised on this page is comparative-endocrinology and genetics work, and it does not report human safety outcomes, tolerability data or adverse-event tables for administered vasotocin. The animal studies cited here described behavioural and tissue-level outcomes — motivation to call in treefrogs (PMID 34401940), social and non-social behaviour in waxbills (PMID 39299181), and spermatogenesis in zebrafish (PMID 38928267) — rather than safety endpoints. Because of that, no safety profile can be stated from these sources, and none is implied here.

Limitations of the current literature

• Species gap. Most primary evidence comes from fish, amphibians, reptiles and birds; mammals use vasopressin rather than vasotocin as the endogenous ligand.
• Nomenclature drift. The same receptors have carried different names across species and decades, which the 2021 universal nomenclature paper set out to resolve (PMID 33911268).
• Behavioural specificity. Effects are often partial: the treefrog study reported an effect on calling motivation but not on calling plasticity (PMID 34401940).
• Human data are indirect. Human findings are genotype-association results (PMID 37990008, PMID 35757177), not administration trials.

References

• Universal nomenclature for oxytocin-vasotocin ligand and receptor families (Nature, 2021)
• Arginine Vasotocin, the Social Neuropeptide of Amphibians and Reptiles (Frontiers in Endocrinology, 2017)
• Differential activation of vasotocin neurons in contexts that elicit aggression and courtship (Behavioural Brain Research, 2017)
• Social context affects aggression and brain vasotocin and isotocin level in the round goby (Fish Physiology and Biochemistry, 2020)
• Male-specific vasotocin expression in the medaka tuberal hypothalamus: Androgen dependence and probable role in aggression (Molecular and Cellular Endocrinology, 2024)
• The modulation of social and non-social behavior by arginine vasotocin in the common waxbill, Estrilda astrild (Hormones and Behavior, 2024)
• Arginine vasotocin affects motivation to call, but not calling plasticity, in Cope's gray treefrog Hyla chrysoscelis (Journal of Comparative Physiology B, 2022)
• Arginine Vasotocin Directly Regulates Spermatogenesis in Adult Zebrafish (Danio rerio) Testes (International Journal of Molecular Sciences, 2024)
• Knock-out of vasotocin reduces reproductive success in female zebrafish, Danio rerio (Frontiers in Endocrinology, 2023)
• Arg-Vasotocin Directly Activates Isotocin Receptors and Induces COX2 Expression in Ovoviviparous Guppies (Frontiers in Endocrinology, 2021)
• Oxytocin and vasotocin receptor variation and the evolution of human prosociality (Comprehensive Psychoneuroendocrinology, 2022)
• Vasotocin receptor gene genotypes moderate the relationship between cortical thickness and sensory processing (Translational Psychiatry, 2023)